61703-325 : Pamidronate Disodium 6 mg/ml Intravenous Injection, Solution
| NDC: | 61703-325 |
| Labeler: | Hospira Worldwide, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Pamidronate Disodium |
| Dosage Form: | Intravenous Injection, Solution |
| Application #: | ANDA075841 |
| Rev. Date: |
NDC Package Codes:
- 61703-325-18: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (61703‑325‑18) > 10 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Pamidronate Disodium
Dosage Strength:
- 6 mg/mL
Pharmaceutical Classes:
- Bisphosphonate [EPC]
- Diphosphonates [CS]
Related Products:
Based on records with the same trade name.- 61703-324 Pamidronate Disodium 3 mg/ml Intravenous Injection, Solution by Hospira Worldwide, Inc.
- 61703-326 Pamidronate Disodium 9 mg/ml Intravenous Injection, Solution by Hospira Worldwide, Inc.
- 61703-356 Pamidronate Disodium 9 mg/ml Intravenous Injection, Solution by Hospira Worldwide, Inc.
- 0069-0107 Pamidronate Disodium 3 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-0109 Pamidronate Disodium 9 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-0186 Pamidronate Disodium 3 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0517-0745 Pamidronate Disodium 3 mg/ml Intravenous Injection, Solution by American Regent, Inc.
- 0517-0746 Pamidronate Disodium 9 mg/ml Intravenous Injection, Solution by American Regent, Inc.
- 0703-4075 Pamidronate Disodium 3 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
- 0703-4085 Pamidronate Disodium 9 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
- 25021-802 Pamidronate Disodium 3 mg/ml Intravenous Injection by Sagent Pharmaceuticals
- 25021-803 Pamidronate Disodium 9 mg/ml Intravenous Injection by Sagent Pharmaceuticals
- 55390-127 Pamidronate Disodium 30 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
- 55390-129 Pamidronate Disodium 90 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
- 55390-204 Pamidronate Disodium 3 mg/ml Intravenous Injection, Solution by Bedford Laboratories
- 59923-601 Pamidronate Disodium 3 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Areva Pharmaceuticals Inc.
- 59923-602 Pamidronate Disodium 6 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Areva Pharmaceuticals Inc.
- 59923-603 Pamidronate Disodium 9 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Areva Pharmaceuticals Inc.
- 63323-734 Pamidronate Disodium 3 mg/ml Intravenous Injection, Solution by App Pharmaceuticals, LLC
- 63323-735 Pamidronate Disodium 9 mg/ml Intravenous Injection, Solution by App Pharmaceuticals, LLC
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 61703-324Next: 61703-326 >
Related Discussions:
pamidronate and dehydration
How important is hydration before and after 90 mg IV ## Hello, Cord! How are you? It really depends, it can cause diarrh... 2 replies
How important is hydration before and after 90 mg IV ## Hello, Cord! How are you? It really depends, it can cause diarrh... 2 replies
substitute for pamidronate
drug for bone cancer-...
drug for bone cancer-...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
